Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma

The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. Specifically, we will assess the positivity rates, both patient-based and lesion-based (total and by district), of the two methods during staging and at the completion of therapy. An interim analysis will be conducted comparing the two methods, followed by a final prognostic analysis.

NCT Number	NCT06659276
Lead Sponsor	IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions	Multiple Myeloma
Enrollment	83 participants
Start Date	2022-09-01
Primary Completion	2024-11 (estimated)
Study Completion	2027-10-10 (estimated)
Updated on ClinicalTrials.gov	2024-10-26